ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
Promotion
Recombinantタンパク質s ClearClear history
Recombinantタンパク質s CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |Omicron specific antibody Hot |Claudin 18.2 |Cadherin-17
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > BDNF

BDNF

概要

Name:Brain-derived neurotrophic factor
Target Synonym:Brain-Derived Neurotrophic Factor,Abrineurin,ANON2,Brain Derived Neurotrophic Factor,BULN2,ProBDNF,Neurotrophin
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:8
Lastest Research Phase:Approved

製品リスト製品比較と製品注文

製品> フィルター結果
製品仕様別：
製品カテゴリー別：
種類別：
タグ別：
コンジュゲート：
製造番号 種類 製品説明 構造 純度 特徴
BDF-H5219 Human Human BDNF / Abrineurin Protein, premium grade
BDF-H5219-structure
BDF-H5219-sds
ACRO Quality

生物活性データの一部

BDF-H5219-MALS-HPLC
BDNF ELISA

Immobilized Human BDNF, premium grade (Cat. No. BDF-H5219) at 1 μg/mL (100 μL/well) can bind Human TrkB, His Tag (Cat. No. NT2-H5228) with a linear range of 2-78 ng/mL (QC tested).

Protocol

Synonym Name

BDNF,ANON2,BULN2,Abrineurin

Background

Brain-derived neurotrophic factor (BDNF) along with nerve growth factor (NGF), neurotrophin-3 (NT-3), and neurotrophin-4/5 (NT-4/5) are members of the neurotrophin family of trophic factors. The neurotrophins play essential roles in the development, survival, and function of a wide range of neurons in both the peripheral and central nervous systems. The neurotrophins interact with two cell surface receptors, the low affinity P75 receptor and the Trk family of high affinity tyrosine kinase receptors. NGF preferentially binds TrkA, BDNF and NT4/5 bind TrkB, and NT-3 binds TrkC (and TrkA to a lesser extent).

Clinical and Translational Updates

公開薬物情報

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Laquinimod Sodium SAIK-MS; TV-5600; ABR-215062 Approved Active Biotech Ab Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis; Huntington Disease; Uveitis; Arthritis; Eye Diseases; Crohn Disease Details

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
Tetramethylpyrazine Nitrone Phase 3 Clinical Jinan University Diabetes Mellitus, Type 2; Stroke; Diabetic Nephropathies; Amyotrophic Lateral Sclerosis Details
ACT-01 ACT-01; OCS-05; BN-201; G-79 Phase 2 Clinical Promius Pharma Keratosis, Actinic; Optic Neuritis; Demyelinating Diseases Details
MP-101 MP101; MP-101 Phase 2 Clinical Mitochon Pharmaceuticals Multiple Sclerosis; Huntington Disease; Amyotrophic Lateral Sclerosis Details
ALTO-100 ALTO-100 Phase 2 Clinical Alto Neuroscience Inc Depressive Disorder, Major; Stress Disorders, Post-Traumatic Details
AC-102 AC-102 Phase 2 Clinical AudioCure Pharma GmbH Tinnitus; Hearing Loss, Sensorineural; Hearing Loss, Sudden Details
TTI-0102 TTI-0102 Phase 2 Clinical Va Office Of Research And Development Coronavirus Disease 2019 (COVID-19); Stress Disorders, Post-Traumatic Details
JS1-1-01 JS1-1-01 Phase 2 Clinical Tianjin Tasly Pharmaceutical Co Ltd Depressive Disorder, Major; Depression; Depressive Disorder Details
AAV2-BDNF gene therapy (University Of California San Diego) Phase 1 Clinical University Of California San Diego Alzheimer Disease; Cognitive Dysfunction Details

This web search service is supported by Google Inc.

totopphone
Call us
お問い合わせ
グローバル：+1 800-810-0816(Toll Free)
日本：+(0)81-50-547-99099
Email
メールアドレス
order.jp@acrobiosystems.com
Fax
ファックス
+1 888-377-6111
Address
株式会社アクロバイオシステムズ
〒157-0066
東京都世田谷区成城1丁目26番9-101号

アクロバイオシステムズの公式アカウント

linkedin twitter facebook youtube

お問い合わせ（半角英文字で入力してください）

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap